Regulus Therapeutics
RGLS
$1.37
Share price
0.74%
Change (1 day)
-8.05%
Change (1 year)
Categories
Regulus Therapeutics (RGLS) - Total assets
Total assets on the balance sheet as of June 2023 : $43.64 M
According to Regulus Therapeutics's latest financial reports the company's total assets are $43.64 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $46.71 M | -31.76% |
| 2021-12-31 | $68.45 M | 82.04% |
| 2020-12-31 | $37.6 M | -10.64% |
| 2019-12-31 | $42.08 M | 50.68% |
| 2018-12-31 | $27.92 M | -64.11% |
| 2017-12-31 | $77.8 M | -22.7% |
| 2016-12-31 | $0.10 B | -28.65% |
| 2015-12-31 | $0.14 B | -17.73% |
| 2014-12-31 | $0.17 B | 39.34% |
| 2013-12-31 | $0.12 B | 18.88% |
| 2012-12-31 | $0.10 B | 141.41% |
| 2011-12-31 | $42.88 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $136.23 B | 312,026.84% | 🇫🇷 France |
 Biogen BIIB | $25.15 B | 57,536.95% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $93.48 B | 214,093.42% | 🇺🇸 USA |
 AstraZeneca AZN | $96.54 B | 221,090.46% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $75.00 B | 171,751.22% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $0.32 B | 644.78% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.40 B | 7,695.27% | 🇺🇸 USA |